Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Kaposi sarcoma in a fingolimod-treated patient with multiple sclerosis.
Hydrogen-rich water improves neurological functional recovery in experimental autoimmune encephalomyelitis mice.
Neuroimmunology: Clostridium-reactive T cells are implicated in the pathogenesis of neuromyelitis optica.
[Neurophysiology in Guillain-Barré syndrome].
New data reinforce efficacy of TECFIDERA® (dimethyl fumarate) in MS patients with high disease activity
Secondary Progressive Multiple Sclerosis: Definition and Measurement.
Neuro-Immune Interactions at Barrier Surfaces.
Geography in multiple sclerosis.
Mutually enhancing anti-inflammatory activities of dimethyl fumarate and NF-κB inhibitors - Implications for dose-sparing combination therapies.
Will the real multiple sclerosis please stand up?
Disease-modifying drugs for multiple sclerosis in pregnancy: A systematic review.
Immuno-modulatory Properties of a Quinolin-2-(1H)-on-3-carboxamide Derivative: Relevance in Multiple Sclerosis.
Effect of BG-12 on contrast-enhanced lesions in patients with relapsing--remitting multiple sclerosis: subgroup analyses from the phase 2b study.
Genetic variation in the IL7RA/IL7 pathway increases multiple sclerosis susceptibility.
Compliance to fingolimod and other disease modifying treatments in multiple sclerosis patients, a retrospective cohort study.
The pathogenesis of demyelinating form of Guillain-Barre syndrome: proteo-peptidomic and immunological profiling of physiological fluids.
Regulation of dimethyl-fumarate toxicity by proteasome inhibitors.
Fumaric acid esters promote neuronal survival upon ischemic stress through activation of the Nrf2 but not HIF-1 signaling pathway.
Pattern of remyelination in the CNS.
Biogen Idec and Abbott Announce Enrollment of First Patient in Global Phase III Study of Daclizumab for Relapse Remitting Multiple Sclerosis
European Medicines Agency accepts Marketing Authorization Application for conditional approval of masitinib in the treatment of pancreatic cancer
Imidazol-1-ylethylindazole voltage-gated sodium channel ligands are neuroprotective during optic neuritis in a mouse model of multiple sclerosis.
Biogen slips as FDA extends review of MS drug
Multi-parametric quantitative MRI of normal appearing white matter in multiple sclerosis, and the effect of disease activity on T2.
Effect of disease-modifying drugs on cortical lesions and atrophy in relapsing-remitting multiple sclerosis.

Pages